Please assess the completion status of the following clinical trial:

Trial Title: Effectiveness and Safety Study for JNJ-18054478 in Asthma Patients.

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE2
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Medically confirmed diagnosis of persistent asthma~* Able to demonstrate reversibility of at least 12% with albuterol inhalation~* Use of short-acting b-2 agonists for rescue \>= 5 times within 2 weeks prior~* Able to produce an FEV1 between 45 and 85% of predicted~* Willing to perform study procedures for about 14 weeks.~Exclusion Criteria:~* Use of inhaled corticosteroids within 4 weeks~* Use of oral/parenteral corticosteroids within 8 weeks~* Use of long-acting beta-2 agonists or montelukast within 2 weeks~* History of life-threatening asthma attack within 3 months~* Female of child bearing potential.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 65 Years
- Healthy Volunteers: f

Study Arms:
- 002 (Type: EXPERIMENTAL): sham comparator 3(100 mg) tablets once daily for 12 weeks
- 001 (Type: EXPERIMENTAL): JNJ-18054478 3(100 mg) tablets once daily for 12 weeks

Based on this trial design, predict the completion outcome and termination type (if applicable).